MOLECULAR IMAGING AND TARGETED THERAPY 2nd Edition

The basics of nuclear chemistry, radiochemistry, and radiopharmacology are considered in detail, regulatory issues are reviewed, and potential applications in drug development, translational medicine, clinical diagnostics, and targeted therapy are discussed.

What is the content of "Molecular Imaging and Targeted Therapy" ?

Compared with the first edition, the chapters on targeted therapy with alpha- and beta-emitting radiopharmaceuticals and theranostics are completely new. Other chapters have been updated and revised as necessary.

Radioisotope-based molecular imaging probes (radiopharmaceuticals) provide unprecedented insights into biochemistry and function in both normal and diseased states of living systems, with unbiased in vivo measurements of regional radiotracer activities offering very high specificity and sensitivity. No other molecular imaging technology, including functional magnetic resonance imaging, can provide such high sensitivity and specificity at a tracer level.

This book, written by an experienced radiochemist and scientist, offers valuable insights into the full range of applications of this technology.

Who is the author of "Molecular Imaging and Targeted Therapy" ?

Dr. Shankar Vallabhajosula graduated from Andhra University with a BS and MS in Pharmacy and subsequently obtained his Ph.D. from the University of Southern California, in 1980.

After receiving the doctorate, he first worked at Mount Sinai Medical Center in New York and since 1997 has been a Professor of Radiochemistry and Radiopharmacy in Radiology at Weill Cornell Medicine of Cornell University and New York Presbyterian Hospital.

He is now the Professor Emeritus in Radiology at Weill Cornell Medicine.